Overview

Ferric Carboxymaltose With or Without Phosphate Substitution for the Treatment of Iron Deficiency or Iron Deficiency Anemia

Status:
Not yet recruiting

Trial end date:
2024-10-17

Target enrollment:

Participant gender:

Summary

This is a confirmatory trial to establish superior serum phosphate stability associated with use of Phoscap® compared with placebo as a supplement for treatment of iron deficiency or iron deficiency anemia with Ferinject® before elective surgery.

Phase:

Phase 4

Details

Lead Sponsor:

Donat R. Spahn

Collaborators:

University of Zurich
Vifor Pharma